摘要
目的分析分布在不同治疗单元的老年2型糖尿病人的降糖治疗方案。方法收集368位住院的老年2型糖尿病人资料,分为心血管疾病组、脑血管疾病组、老年病组、内分泌组,评价降糖方案的合理性。结果二甲双胍、阿卡波糖的使用均存在禁忌证(P>0.05),非内分泌专业组使用二甲双胍的不合理现象较多。共有59.2%的病人使用2种以上的降糖药物,出现了降糖药物相互间的作用以及降糖药物与烟酒、降糖药物与其他口服药物的相互作用。结论老年2型糖尿病人的降糖治疗方案需要综合考虑年龄、肝肾功能、胰岛功能、合并疾病、药物相互作用等因素。建议制订住院糖尿病人的管理计划,指定专人负责管理和协调有关住院糖尿病人管理的治疗系统。
OBJECTIVE To analysis of hypoglycemic treatment in elderly type 2 diabetic patients with different treatment units.METHODS Collect 368 data of hospitalized elderly type 2 diabetes patients, Divided into cardiovascular disease group,cerebrovascular disease group,senile disease group,endocrine group. We evaluation of rationality of Sugar reduction Program.RESULTS The use of metformin and acarbose had contraindications( P > 0. 05). There were more unreasonable use of metformin in non-endocrine specialty grup. More than half of the patients use more than 2 hypoglycemic drugs. There were interactions between hypoglycemic drugs,hypoglycemic drugs and tobacco and alcohol,hypoglycemic drugs and other oral drugs. CONCLUSION Age,liver and kidney function,islet function,complicated disease and drug interaction should be taken into account in the treatment of type2 diabetes mellitus. It is recommended that a management plan for hospitalized diabetic patients be drawn up. A designated person is responsible for the management and coordination of the treatment system for hospitalized diabetics.
作者
高玉霞
肖卫东
GAO Yuxia;XIAO Weidong(Department of Pharmacy,Dongying Shengli Hospital,Dongying,Shandong 257055,China)
出处
《今日药学》
CAS
2019年第1期842-845,共4页
Pharmacy Today
关键词
不同治疗单元
住院老年2型糖尿病人
降糖方案分析
different teatment units
Hospitalized elderly patients with type 2 diabetes
Analysis of hypoglycemic scheme